These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23561681)

  • 1. Inter-arm blood pressure differences compared with ambulatory monitoring: a manifestation of the 'white-coat' effect?
    Martin U; Holder R; Hodgkinson J; McManus R
    Br J Gen Pract; 2013 Feb; 63(607):e97-103. PubMed ID: 23561681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Task force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring.
    Staessen JA; Beilin L; Parati G; Waeber B; White W
    Blood Press Monit; 1999 Dec; 4(6):319-31. PubMed ID: 10602536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In the aftermath of SPRINT: further comparison of unattended automated office blood pressure measurement and 24-hour blood pressure monitoring.
    Seidlerová J; Gelžinský J; Mateřánková M; Ceral J; König P; Filipovský J
    Blood Press; 2018 Oct; 27(5):256-261. PubMed ID: 29566565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the white-coat effect among hypertensive patients presumed to be at goal.
    Bookstaver DA; Hatzigeorgiou C
    Ann Pharmacother; 2011 Jul; 45(7-8):910-5. PubMed ID: 21750311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-arm blood pressure differences compare with ambulatory monitoring: a manifestation of the 'white-coat' effect?
    Nieuwenhuize R; Geuze J; Oppewal A
    Br J Gen Pract; 2013 May; 63(610):237. PubMed ID: 23643208
    [No Abstract]   [Full Text] [Related]  

  • 7. Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the 'white-coat' effect. Syst-Eur investigators.
    Parati G; Omboni S; Staessen J; Thijs L; Fagard R; Ulian L; Mancia G
    J Hypertens; 1998 Jan; 16(1):23-9. PubMed ID: 9533413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension.
    Muxfeldt ES; Fiszman R; de Souza F; Viegas B; Oliveira FC; Salles GF
    Hypertension; 2012 Feb; 59(2):384-9. PubMed ID: 22215711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interarm Difference in Systolic Blood Pressure in Different Ethnic Groups and Relationship to the "White Coat Effect": A Cross-Sectional Study.
    Schwartz CL; Clark C; Koshiaris C; Gill PS; Greenfield SM; Haque SM; Heer G; Johal A; Kaur R; Mant J; Martin U; Mohammed MA; Wood S; McManus RJ
    Am J Hypertens; 2017 Sep; 30(9):884-891. PubMed ID: 28475667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large discrepancy between unobserved automated office blood pressure and ambulatory blood pressure in a high cardiovascular risk cohort.
    Seo J; Lee CJ; Oh J; Lee SH; Kang SM; Park S
    J Hypertens; 2019 Jan; 37(1):42-49. PubMed ID: 30507862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating different criteria for defining a complete ambulatory blood pressure monitoring recording: data from the Jackson Heart Study.
    Bromfield SG; Booth JN; Loop MS; Schwartz JE; Seals SR; Thomas SJ; Min YI; Ogedegbe G; Shimbo D; Muntner P
    Blood Press Monit; 2018 Apr; 23(2):103-111. PubMed ID: 29240564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension.
    Veglio F; Rabbia F; Riva P; Martini G; Genova GC; Milan A; Paglieri C; Carra R; Chiandussi L
    Clin Exp Hypertens; 2001 Apr; 23(3):203-11. PubMed ID: 11339687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of clinical and ambulatory measurements of blood pressure with benazepril alone or combined with hydrochlorothiazide in hypertension].
    Le Feuvre C; Francillon A; Renucci JF; Cocco-Guyomarch L; Muller M; Peuplier P; Poggi L
    Therapie; 1996; 51(1):27-34. PubMed ID: 8762217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three Hours Ambulatory Blood Pressure: A Surrogate for Daytime Ambulatory Blood Pressure Assessment in the Pakistani Population.
    Shahab H; Khan HS; Tufail M; Artani A; Almas A; Shah HA; Khan AH
    Cureus; 2021 Aug; 13(8):e17433. PubMed ID: 34589341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Out-of-Office Blood Pressure in the Clinic (PROOF-BP): Derivation and Validation of a Tool to Improve the Accuracy of Blood Pressure Measurement in Clinical Practice.
    Sheppard JP; Stevens R; Gill P; Martin U; Godwin M; Hanley J; Heneghan C; Hobbs FD; Mant J; McKinstry B; Myers M; Nunan D; Ward A; Williams B; McManus RJ
    Hypertension; 2016 May; 67(5):941-50. PubMed ID: 27001299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood Pressure Monitoring. Task force III: Target-organ damage, morbidity and mortality.
    Verdecchia P; Clement D; Fagard R; Palatini P; Parati G
    Blood Press Monit; 1999 Dec; 4(6):303-17. PubMed ID: 10602535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White-coat effect in normotension and hypertension.
    Zakopoulos NA; Kotsis VT; Pitiriga VCh; Toumanidis ST; Lekakis JP; Nanas SN; Vemmos KN; Stamatelopoulos SF; Moulopoulos SD
    Blood Press Monit; 2002 Oct; 7(5):271-6. PubMed ID: 12409886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential follow-up clinic and ambulatory blood pressure evaluation in a low risk population of white-coat hypertensive patients and in normotensives.
    Polónia JJ; Gama GM; Silva JA; Amaral C; Martins LR; Bertoquini SE
    Blood Press Monit; 2005 Apr; 10(2):57-64. PubMed ID: 15812251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar results with 1-hour and 24-hour ambulatory blood pressure measurement in elderly people with hypertension.
    Stender BS; Stender J
    Dan Med J; 2023 Mar; 70(4):. PubMed ID: 36999815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.